| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.946 | 0.004 | 0.954 | Cyclophilin D inhibitor | 0.938 0.004 DBMET03593 0.954 0.004 DBMET03594 0.946 0.004 DBMET03595 0.911 0.005 DBMET03596 | DBMET03594 | |
| 0.851 | 0 | 0.873 | Sodium/glucose cotransporter inhibitor | 0.873 0 DBMET03593 0.546 0.001 DBMET03594 0.864 0 DBMET03595 0.446 0.001 DBMET03596 | DBMET03593 | |
| 0.836 | 0 | 0.855 | Sodium/glucose cotransporter 2 inhibitor | 0.855 0 DBMET03593 0.457 0 DBMET03594 0.83 0 DBMET03595 0.381 0.001 DBMET03596 | DBMET03593 | |
| 0.793 | 0.004 | 0.826 | Hypoglycemic | 0.824 0.004 DBMET03593 0.826 0.004 DBMET03594 0.821 0.004 DBMET03595 0.666 0.005 DBMET03596 | DBMET03594 | |
| 0.737 | 0.006 | 0.874 | Cholesterol antagonist | 0.874 0.003 DBMET03593 0.76 0.005 DBMET03594 0.682 0.009 DBMET03595 0.788 0.004 DBMET03596 | DBMET03593 | |
| 0.709 | 0.01 | 0.73 | Antiobesity | 0.594 0.021 DBMET03593 0.73 0.009 DBMET03594 0.672 0.013 DBMET03595 0.712 0.01 DBMET03596 | DBMET03594 | |
| 0.658 | 0.025 | 0.868 | Transcription factor NF kappa B inhibitor | 0.868 0.009 DBMET03593 0.666 0.024 DBMET03594 0.656 0.025 DBMET03595 0.63 0.028 DBMET03596 | DBMET03593 | |
| 0.591 | 0.003 | 0.777 | AMP-activated protein kinase stimulant | 0.777 0.002 DBMET03593 0.525 0.003 DBMET03594 0.603 0.003 DBMET03595 0.323 0.005 DBMET03596 | DBMET03593 | |
| 0.551 | 0.022 | 0.813 | Antithrombotic | 0.813 0.004 DBMET03593 0.62 0.014 DBMET03594 0.464 0.035 DBMET03595 0.615 0.015 DBMET03596 | DBMET03593 | |
| 0.486 | 0.007 | 0.536 | Melanin inhibitor | 0.508 0.006 DBMET03593 0.471 0.008 DBMET03594 0.536 0.005 DBMET03595 0.378 0.013 DBMET03596 | DBMET03595 | |
| 0.472 | 0.024 | 0.616 | Antioxidant | 0.616 0.01 DBMET03593 0.466 0.024 DBMET03594 0.476 0.023 DBMET03595 0.44 0.028 DBMET03596 | DBMET03593 | |
| 0.438 | 0.009 | 0.504 | Platelet adhesion inhibitor | 0.504 0.005 DBMET03593 0.444 0.008 DBMET03594 0.407 0.011 DBMET03595 0.435 0.009 DBMET03596 | DBMET03593 | |
| 0.469 | 0.05 | 0.684 | Antibacterial | 0.684 0.01 DBMET03593 0.452 0.056 DBMET03594 0.451 0.057 DBMET03595 0.453 0.056 DBMET03596 | DBMET03593 | |
| 0.426 | 0.008 | 0.631 | Amylase inhibitor | 0.622 0.004 DBMET03593 0.544 0.005 DBMET03594 0.631 0.004 DBMET03595 0.286 0.02 DBMET03596 | DBMET03595 | |
| 0.442 | 0.029 | 0.551 | Apoptosis antagonist | 0.551 0.014 DBMET03593 0.495 0.021 DBMET03594 0.467 0.025 DBMET03595 0.418 0.033 DBMET03596 | DBMET03593 | |
| 0.427 | 0.02 | 0.509 | Hypolipemic | 0.435 0.019 DBMET03593 0.458 0.016 DBMET03594 0.416 0.023 DBMET03595 0.509 0.012 DBMET03596 | DBMET03596 | |
| 0.472 | 0.072 | 0.516 | Caspase 9 stimulant | 0.443 0.087 DBMET03593 0.512 0.055 DBMET03594 0.516 0.054 DBMET03595 0.354 0.142 DBMET03596 | DBMET03595 | |
| 0.491 | 0.091 | 0.718 | Antiinflammatory | 0.718 0.028 DBMET03593 0.409 0.134 DBMET03594 0.457 0.107 DBMET03595 0.592 0.056 DBMET03596 | DBMET03593 | |
| 0.48 | 0.081 | 0.618 | Apoptosis agonist | 0.618 0.045 DBMET03593 0.42 0.104 DBMET03594 0.468 0.084 DBMET03595 0.42 0.104 DBMET03596 | DBMET03593 | |
| 0.438 | 0.05 | 0.525 | Immunosuppressant | 0.525 0.026 DBMET03593 0.371 0.076 DBMET03594 0.396 0.064 DBMET03595 0.445 0.049 DBMET03596 | DBMET03593 | |
| 0.406 | 0.028 | 0.549 | Free radical scavenger | 0.549 0.012 DBMET03593 0.414 0.026 DBMET03594 0.402 0.028 DBMET03595 0.351 0.039 DBMET03596 | DBMET03593 | |
| 0.416 | 0.045 | 0.603 | Immunostimulant | 0.603 0.016 DBMET03593 0.41 0.047 DBMET03594 0.39 0.053 DBMET03595 0.386 0.054 DBMET03596 | DBMET03593 | |
| 0.404 | 0.034 | 0.522 | Vasodilator, coronary | 0.462 0.021 DBMET03593 0.522 0.013 DBMET03594 0.469 0.02 DBMET03595 0.441 0.025 DBMET03596 | DBMET03594 | |
| 0.429 | 0.061 | 0.641 | Histamine release inhibitor | 0.641 0.007 DBMET03593 0.41 0.07 DBMET03594 0.489 0.033 DBMET03595 0.467 0.042 DBMET03596 | DBMET03593 | |
| 0.388 | 0.024 | 0.646 | Angiogenesis stimulant | 0.646 0.005 DBMET03593 0.354 0.031 DBMET03594 0.375 0.026 DBMET03595 0.37 0.028 DBMET03596 | DBMET03593 | |
| 0.37 | 0.007 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.375 0.007 DBMET03593 0.4 0.006 DBMET03594 0.432 0.004 DBMET03595 0.34 0.008 DBMET03596 | DBMET03595 | |
| 0.361 | 0.028 | 0.405 | DNA synthesis inhibitor | 0.405 0.021 DBMET03593 0.337 0.033 DBMET03594 0.394 0.022 DBMET03595 0.349 0.03 DBMET03596 | DBMET03593 | |
| 0.341 | 0.015 | 0.381 | Interferon gamma antagonist | 0.381 0.012 DBMET03593 0.321 0.017 DBMET03594 0.306 0.019 DBMET03595 0.277 0.024 DBMET03596 | DBMET03593 | |
| 0.351 | 0.045 | 0.391 | Interleukin 2 agonist | 0.391 0.03 DBMET03593 0.37 0.037 DBMET03594 0.353 0.044 DBMET03595 0.343 0.049 DBMET03596 | DBMET03593 | |
| 0.328 | 0.023 | 0.467 | Hepatoprotectant | 0.467 0.009 DBMET03593 0.333 0.022 DBMET03594 0.313 0.026 DBMET03595 0.316 0.025 DBMET03596 | DBMET03593 | |
| 0.318 | 0.015 | 0.325 | NOS3 expression enhancer | 0.318 0.015 DBMET03593 0.325 0.014 DBMET03594 0.324 0.014 DBMET03595 0.267 0.023 DBMET03596 | DBMET03594 | |
| 0.311 | 0.015 | 0.343 | Protein kinase stimulant | 0.322 0.014 DBMET03593 0.262 0.023 DBMET03594 0.343 0.012 DBMET03595 0.154 0.065 DBMET03596 | DBMET03595 | |
| 0.335 | 0.045 | 0.347 | DNA damaging | 0.347 0.042 DBMET03593 0.246 0.082 DBMET03594 0.346 0.042 DBMET03595 0.2 0.115 DBMET03596 | DBMET03593 | |
| 0.293 | 0.006 | 0.565 | Cyclooxygenase 3 inhibitor | 0.565 0.003 DBMET03593 0.249 0.009 DBMET03594 0.264 0.008 DBMET03595 0.233 0.011 DBMET03596 | DBMET03593 | |
| 0.324 | 0.045 | 0.431 | Tumour necrosis factor alpha release inhibitor | 0.431 0.022 DBMET03593 0.267 0.067 DBMET03594 0.236 0.082 DBMET03595 0.211 0.099 DBMET03596 | DBMET03593 | |
| 0.324 | 0.069 | 0.324 | Calcium channel activator | 0.309 0.083 DBMET03594 0.278 0.115 DBMET03595 | ||
| 0.294 | 0.042 | 0.407 | Nitric oxide antagonist | 0.407 0.025 DBMET03593 0.282 0.044 DBMET03594 0.296 0.041 DBMET03595 0.291 0.042 DBMET03596 | DBMET03593 | |
| 0.26 | 0.008 | 0.38 | Selectin antagonist | 0.38 0.004 DBMET03593 0.277 0.007 DBMET03594 0.264 0.008 DBMET03595 0.232 0.009 DBMET03596 | DBMET03593 | |
| 0.268 | 0.016 | 0.346 | Insulin secretagoues | 0.346 0.009 DBMET03593 0.33 0.01 DBMET03594 0.314 0.011 DBMET03595 0.172 0.054 DBMET03596 | DBMET03593 | |
| 0.322 | 0.071 | 0.484 | Immunomodulator | 0.484 0.026 DBMET03593 0.245 0.119 DBMET03594 0.32 0.072 DBMET03595 0.318 0.073 DBMET03596 | DBMET03593 | |
| 0.331 | 0.082 | 0.445 | Vasodilator, peripheral | 0.228 0.146 DBMET03593 0.445 0.042 DBMET03594 0.381 0.061 DBMET03595 0.279 0.108 DBMET03596 | DBMET03594 | |
| 0.252 | 0.004 | 0.303 | Phosphorylase inhibitor | 0.224 0.004 DBMET03593 0.303 0.003 DBMET03594 0.277 0.004 DBMET03595 0.167 0.006 DBMET03596 | DBMET03594 | |
| 0.257 | 0.016 | 0.266 | DNA polymerase I inhibitor | 0.213 0.024 DBMET03593 0.266 0.015 DBMET03594 0.203 0.027 DBMET03595 0.246 0.018 DBMET03596 | DBMET03594 | |
| 0.264 | 0.031 | 0.279 | Neurotrophic factor enhancer | 0.213 0.064 DBMET03593 0.272 0.027 DBMET03594 0.279 0.025 DBMET03595 0.182 0.095 DBMET03596 | DBMET03595 | |
| 0.263 | 0.042 | 0.366 | RNA-directed DNA polymerase inhibitor | 0.217 0.077 DBMET03593 0.366 0.022 DBMET03594 0.344 0.025 DBMET03595 0.211 0.085 DBMET03596 | DBMET03594 | |
| 0.245 | 0.026 | 0.283 | Phospholipase C inhibitor | 0.147 0.112 DBMET03593 0.23 0.03 DBMET03594 0.283 0.02 DBMET03595 0.149 0.109 DBMET03596 | DBMET03595 | |
| 0.239 | 0.041 | 0.435 | Insulin sensitizer | 0.181 0.094 DBMET03593 0.435 0.005 DBMET03594 0.259 0.03 DBMET03595 | DBMET03594 | |
| 0.261 | 0.068 | 0.439 | Platelet antagonist | 0.339 0.041 DBMET03593 0.439 0.021 DBMET03594 0.196 0.104 DBMET03595 0.347 0.039 DBMET03596 | DBMET03594 | |
| 0.22 | 0.031 | 0.245 | Interleukin 6 antagonist | 0.245 0.024 DBMET03593 0.189 0.048 DBMET03594 0.227 0.029 DBMET03595 0.142 0.102 DBMET03596 | DBMET03593 | |
| 0.213 | 0.028 | 0.27 | ATPase inhibitor | 0.27 0.01 DBMET03593 0.249 0.014 DBMET03594 0.189 0.048 DBMET03595 0.175 0.064 DBMET03596 | DBMET03593 | |
| 0.207 | 0.025 | 0.207 | Cholesterol synthesis inhibitor | 0.132 0.055 DBMET03593 0.166 0.037 DBMET03594 0.149 0.045 DBMET03595 0.174 0.034 DBMET03596 | ||
| 0.248 | 0.07 | 0.302 | Vasodilator | 0.302 0.047 DBMET03593 0.272 0.059 DBMET03594 0.262 0.063 DBMET03595 0.208 0.099 DBMET03596 | DBMET03593 | |
| 0.197 | 0.025 | 0.363 | Cell adhesion inhibitor | 0.363 0.006 DBMET03593 0.264 0.013 DBMET03594 0.189 0.028 DBMET03595 0.19 0.028 DBMET03596 | DBMET03593 | |
| 0.234 | 0.063 | 0.359 | Peptidyltransferase inhibitor | 0.359 0.011 DBMET03593 0.246 0.053 DBMET03594 0.256 0.047 DBMET03595 0.226 0.07 DBMET03596 | DBMET03593 | |
| 0.197 | 0.027 | 0.282 | Alkylator | 0.282 0.014 DBMET03593 0.168 0.038 DBMET03594 0.206 0.024 DBMET03595 0.173 0.036 DBMET03596 | DBMET03593 | |
| 0.202 | 0.033 | 0.33 | Monophenol monooxygenase inhibitor | 0.325 0.015 DBMET03593 0.33 0.015 DBMET03594 0.315 0.016 DBMET03595 0.112 0.067 DBMET03596 | DBMET03594 | |
| 0.196 | 0.029 | 0.385 | Aldehyde dehydrogenase inhibitor | 0.13 0.062 DBMET03593 0.374 0.006 DBMET03594 0.385 0.006 DBMET03595 0.196 0.029 DBMET03596 | DBMET03595 | |
| 0.177 | 0.01 | 0.183 | Toll-Like receptor 4 antagonist | 0.183 0.009 DBMET03593 0.155 0.019 DBMET03594 0.157 0.017 DBMET03595 0.166 0.014 DBMET03596 | DBMET03593 | |
| 0.253 | 0.087 | 0.253 | 5 Hydroxytryptamine release stimulant | 0.236 0.096 DBMET03593 0.196 0.125 DBMET03594 0.234 0.097 DBMET03595 0.212 0.112 DBMET03596 | ||
| 0.27 | 0.108 | 0.27 | Sodium/bile acid cotransporter inhibitor | 0.217 0.165 DBMET03594 | ||
| 0.178 | 0.019 | 0.178 | Potassium channel (Ca-activated) activator | 0.169 0.022 DBMET03594 0.158 0.025 DBMET03595 0.107 0.05 DBMET03596 | ||
| 0.186 | 0.039 | 0.455 | Hemostatic | 0.455 0.005 DBMET03593 0.181 0.042 DBMET03594 0.164 0.054 DBMET03595 | DBMET03593 | |
| 0.212 | 0.068 | 0.263 | Anesthetic general | 0.169 0.095 DBMET03593 0.149 0.115 DBMET03594 0.263 0.045 DBMET03595 | DBMET03595 | |
| 0.211 | 0.072 | 0.238 | Amyloid beta aggregation inhibitor | 0.138 0.118 DBMET03593 0.197 0.079 DBMET03594 0.238 0.062 DBMET03595 0.148 0.109 DBMET03596 | DBMET03595 | |
| 0.168 | 0.029 | 0.32 | Expectorant | 0.32 0.007 DBMET03593 0.305 0.008 DBMET03594 0.158 0.032 DBMET03595 0.106 0.062 DBMET03596 | DBMET03593 | |
| 0.297 | 0.16 | 0.328 | Calcium channel L-type activator | 0.328 0.134 DBMET03594 0.313 0.146 DBMET03595 | DBMET03594 | |
| 0.201 | 0.07 | 0.395 | Non-steroidal antiinflammatory agent | 0.395 0.014 DBMET03593 0.217 0.059 DBMET03594 0.218 0.058 DBMET03595 | DBMET03593 | |
| 0.186 | 0.059 | 0.353 | Thrombolytic | 0.291 0.025 DBMET03593 0.245 0.035 DBMET03594 0.178 0.063 DBMET03595 0.353 0.016 DBMET03596 | DBMET03596 | |
| 0.152 | 0.028 | 0.184 | Carbonic anhydrase III inhibitor | 0.108 0.054 DBMET03593 0.152 0.028 DBMET03594 0.184 0.019 DBMET03595 0.131 0.037 DBMET03596 | DBMET03595 | |
| 0.198 | 0.074 | 0.198 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.194 0.077 DBMET03594 0.184 0.088 DBMET03595 0.177 0.097 DBMET03596 | ||
| 0.159 | 0.039 | 0.159 | Adenylate cyclase inhibitor | 0.139 0.053 DBMET03594 0.146 0.048 DBMET03595 0.097 0.087 DBMET03596 | ||
| 0.21 | 0.093 | 0.282 | Antiamyloidogenic | 0.282 0.058 DBMET03593 0.172 0.121 DBMET03594 0.25 0.071 DBMET03595 0.179 0.115 DBMET03596 | DBMET03593 | |
| 0.149 | 0.033 | 0.201 | DNA repair enzyme inhibitor | 0.201 0.009 DBMET03593 0.143 0.039 DBMET03594 0.139 0.043 DBMET03595 | DBMET03593 | |
| 0.23 | 0.119 | 0.324 | Hypoxia-inducible factor 1 alpha inhibitor | 0.221 0.128 DBMET03593 0.324 0.055 DBMET03594 0.247 0.103 DBMET03595 | DBMET03594 | |
| 0.168 | 0.063 | 0.168 | Cytidine deaminase inhibitor | 0.151 0.075 DBMET03594 0.112 0.11 DBMET03595 | ||
| 0.127 | 0.025 | 0.185 | NADH dehydrogenase inhibitor | 0.125 0.026 DBMET03593 0.185 0.012 DBMET03594 0.172 0.013 DBMET03595 0.116 0.031 DBMET03596 | DBMET03594 | |
| 0.158 | 0.063 | 0.241 | Lipid peroxidase inhibitor | 0.241 0.029 DBMET03593 0.162 0.06 DBMET03594 0.168 0.056 DBMET03595 0.151 0.068 DBMET03596 | DBMET03593 | |
| 0.127 | 0.034 | 0.221 | Uric acid excretion stimulant | 0.166 0.019 DBMET03593 0.221 0.01 DBMET03594 0.138 0.028 DBMET03595 0.134 0.03 DBMET03596 | DBMET03594 | |
| 0.118 | 0.025 | 0.203 | Cell adhesion molecule inhibitor | 0.203 0.009 DBMET03593 0.157 0.014 DBMET03594 0.103 0.033 DBMET03595 0.135 0.019 DBMET03596 | DBMET03593 | |
| 0.146 | 0.057 | 0.272 | Alpha-N-acetylglucosaminidase inhibitor | 0.135 0.065 DBMET03593 0.272 0.019 DBMET03594 0.215 0.03 DBMET03595 0.128 0.07 DBMET03596 | DBMET03594 | |
| 0.132 | 0.049 | 0.137 | Microtubule formation inhibitor | 0.133 0.048 DBMET03593 0.123 0.057 DBMET03594 0.137 0.045 DBMET03595 | DBMET03595 | |
| 0.115 | 0.033 | 0.15 | Aminoacyl-tRNA synthetase inhibitor | 0.121 0.029 DBMET03594 0.15 0.019 DBMET03595 0.104 0.042 DBMET03596 | DBMET03595 | |
| 0.107 | 0.025 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 DBMET03593 0.081 0.05 DBMET03594 0.095 0.036 DBMET03595 0.126 0.013 DBMET03596 | DBMET03596 | |
| 0.092 | 0.01 | 0.122 | Glucosylceramidase inhibitor | 0.086 0.013 DBMET03595 0.122 0.005 DBMET03596 | DBMET03596 | |
| 0.115 | 0.035 | 0.276 | Triose-phosphate isomerase inhibitor | 0.117 0.034 DBMET03593 0.276 0.005 DBMET03594 0.171 0.015 DBMET03595 | DBMET03594 | |
| 0.087 | 0.008 | 0.087 | Squalene epoxidase inhibitor | 0.047 0.04 DBMET03593 0.063 0.018 DBMET03595 0.054 0.027 DBMET03596 | ||
| 0.199 | 0.12 | 0.421 | Spasmolytic | 0.248 0.092 DBMET03593 0.174 0.142 DBMET03594 0.194 0.124 DBMET03595 0.421 0.036 DBMET03596 | DBMET03596 | |
| 0.169 | 0.091 | 0.169 | P-glycoprotein inhibitor | 0.169 0.091 DBMET03593 0.157 0.106 DBMET03595 0.157 0.106 DBMET03596 | ||
| 0.101 | 0.023 | 0.101 | Potassium channel large-conductance Ca-activated activator | 0.062 0.055 DBMET03593 0.097 0.025 DBMET03594 0.095 0.026 DBMET03595 0.076 0.038 DBMET03596 | ||
| 0.218 | 0.145 | 0.275 | Caspase 3 stimulant | 0.275 0.093 DBMET03593 0.232 0.129 DBMET03594 0.235 0.126 DBMET03595 | DBMET03593 | |
| 0.122 | 0.051 | 0.123 | Estrogen antagonist | 0.102 0.094 DBMET03593 0.122 0.052 DBMET03594 0.123 0.049 DBMET03595 0.121 0.054 DBMET03596 | DBMET03595 | |
| 0.126 | 0.059 | 0.256 | Protein-tyrosine phosphatase 1B inhibitor | 0.147 0.047 DBMET03593 0.256 0.016 DBMET03594 0.118 0.065 DBMET03595 0.098 0.08 DBMET03596 | DBMET03594 | |
| 0.133 | 0.067 | 0.154 | Interleukin 4 antagonist | 0.13 0.072 DBMET03593 0.137 0.063 DBMET03594 0.154 0.046 DBMET03595 0.117 0.089 DBMET03596 | DBMET03595 | |
| 0.147 | 0.081 | 0.298 | Protein-tyrosine phosphatase inhibitor | 0.157 0.071 DBMET03593 0.298 0.019 DBMET03594 0.141 0.088 DBMET03595 0.119 0.115 DBMET03596 | DBMET03594 | |
| 0.102 | 0.037 | 0.152 | Transcription factor NF kappa B stimulant | 0.152 0.015 DBMET03593 0.094 0.046 DBMET03594 0.091 0.05 DBMET03595 0.098 0.041 DBMET03596 | DBMET03593 | |
| 0.103 | 0.043 | 0.103 | Acetylcholine M3 receptor agonist | 0.09 0.052 DBMET03596 | ||
| 0.107 | 0.048 | 0.206 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.09 0.065 DBMET03593 0.206 0.015 DBMET03594 0.151 0.026 DBMET03595 0.093 0.061 DBMET03596 | DBMET03594 | |
| 0.115 | 0.058 | 0.182 | Topoisomerase I inhibitor | 0.182 0.031 DBMET03593 0.131 0.049 DBMET03594 0.135 0.048 DBMET03595 0.098 0.072 DBMET03596 | DBMET03593 | |
| 0.116 | 0.061 | 0.267 | Cystathionine beta-synthase inhibitor | 0.267 0.013 DBMET03594 0.149 0.041 DBMET03595 | DBMET03594 | |
| 0.068 | 0.013 | 0.078 | Mannosidase inhibitor | 0.074 0.01 DBMET03593 0.063 0.015 DBMET03594 0.078 0.009 DBMET03595 0.058 0.018 DBMET03596 | DBMET03595 | |
| 0.181 | 0.126 | 0.207 | Nitric-oxide synthase stimulant | 0.176 0.139 DBMET03593 0.207 0.078 DBMET03594 0.206 0.079 DBMET03595 0.168 0.158 DBMET03596 | DBMET03594 | |
| 0.108 | 0.054 | 0.228 | Xanthine oxidase inhibitor | 0.194 0.021 DBMET03593 0.228 0.015 DBMET03594 0.139 0.039 DBMET03595 | DBMET03594 | |
| 0.089 | 0.035 | 0.09 | Lipase inhibitor | 0.09 0.034 DBMET03593 0.085 0.038 DBMET03595 | DBMET03593 | |
| 0.103 | 0.051 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.052 DBMET03595 | ||
| 0.055 | 0.005 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 DBMET03594 0.055 0.005 DBMET03595 0.051 0.006 DBMET03596 | ||
| 0.097 | 0.048 | 0.19 | Antineoplastic antibiotic | 0.19 0.023 DBMET03593 0.086 0.053 DBMET03594 0.098 0.047 DBMET03595 0.094 0.049 DBMET03596 | DBMET03593 | |
| 0.095 | 0.047 | 0.108 | ATPase (Vacuolar H+) inhibitor | 0.108 0.03 DBMET03593 0.098 0.043 DBMET03594 0.08 0.077 DBMET03595 0.09 0.056 DBMET03596 | DBMET03593 | |
| 0.092 | 0.045 | 0.118 | Carbonic anhydrase VI inhibitor | 0.118 0.03 DBMET03594 0.114 0.032 DBMET03595 | DBMET03594 | |
| 0.054 | 0.007 | 0.087 | Uridine phosphorylase inhibitor | 0.03 0.017 DBMET03593 0.065 0.005 DBMET03594 0.087 0.003 DBMET03595 | DBMET03595 | |
| 0.066 | 0.02 | 0.073 | Alpha-mannosidase inhibitor | 0.069 0.018 DBMET03593 0.071 0.016 DBMET03594 0.073 0.014 DBMET03595 0.058 0.029 DBMET03596 | DBMET03595 | |
| 0.055 | 0.01 | 0.086 | Antibiotic Aminoglycoside-like | 0.086 0.004 DBMET03593 0.051 0.013 DBMET03594 0.054 0.011 DBMET03595 0.054 0.011 DBMET03596 | DBMET03593 | |
| 0.169 | 0.124 | 0.22 | Cyclic AMP phosphodiesterase inhibitor | 0.195 0.098 DBMET03593 0.201 0.093 DBMET03594 0.22 0.08 DBMET03595 0.191 0.101 DBMET03596 | DBMET03595 | |
| 0.073 | 0.029 | 0.078 | Nitric oxide donor | 0.078 0.024 DBMET03593 0.064 0.042 DBMET03594 0.066 0.039 DBMET03595 0.06 0.049 DBMET03596 | DBMET03593 | |
| 0.181 | 0.138 | 0.392 | Cardiotonic | 0.392 0.03 DBMET03596 | DBMET03596 | |
| 0.094 | 0.055 | 0.114 | Thioredoxin inhibitor | 0.095 0.054 DBMET03593 0.114 0.035 DBMET03594 0.1 0.048 DBMET03595 0.088 0.064 DBMET03596 | DBMET03594 | |
| 0.086 | 0.048 | 0.088 | Thioredoxin reductase inhibitor | 0.081 0.059 DBMET03594 0.088 0.044 DBMET03595 0.081 0.059 DBMET03596 | DBMET03595 | |
| 0.09 | 0.055 | 0.09 | Interleukin 5 antagonist | 0.088 0.057 DBMET03593 0.08 0.073 DBMET03595 | ||
| 0.062 | 0.029 | 0.062 | Estrogen agonist | 0.059 0.03 DBMET03593 0.054 0.033 DBMET03594 0.055 0.032 DBMET03595 | ||
| 0.057 | 0.027 | 0.059 | Antimetabolite | 0.059 0.026 DBMET03594 0.054 0.029 DBMET03595 | DBMET03594 | |
| 0.119 | 0.09 | 0.126 | Vanilloid 1 agonist | 0.12 0.088 DBMET03593 0.12 0.088 DBMET03594 0.126 0.075 DBMET03595 | DBMET03595 | |
| 0.057 | 0.028 | 0.128 | Heparanase inhibitor | 0.128 0.003 DBMET03593 0.057 0.028 DBMET03594 0.053 0.038 DBMET03595 0.05 0.044 DBMET03596 | DBMET03593 | |
| 0.071 | 0.047 | 0.174 | Phosphofructokinase-1 inhibitor | 0.115 0.027 DBMET03593 0.174 0.014 DBMET03594 0.111 0.028 DBMET03595 0.061 0.056 DBMET03596 | DBMET03594 | |
| 0.03 | 0.005 | 0.035 | Isoleucine-tRNA ligase inhibitor | 0.026 0.01 DBMET03594 0.035 0.004 DBMET03595 0.026 0.009 DBMET03596 | DBMET03595 | |
| 0.05 | 0.029 | 0.074 | Glucose-6-phosphate isomerase inhibitor | 0.074 0.01 DBMET03594 0.066 0.015 DBMET03595 0.047 0.035 DBMET03596 | DBMET03594 | |
| 0.031 | 0.011 | 0.036 | Adenosine A1 receptor agonist | 0.023 0.018 DBMET03593 0.029 0.013 DBMET03594 0.036 0.009 DBMET03595 0.03 0.012 DBMET03596 | DBMET03595 | |
| 0.127 | 0.109 | 0.134 | Adenylate cyclase stimulant | 0.134 0.094 DBMET03594 0.128 0.105 DBMET03595 | DBMET03594 | |
| 0.048 | 0.033 | 0.048 | Cholesterol esterase inhibitor | |||
| 0.093 | 0.078 | 0.093 | Estrogen receptor beta antagonist | 0.088 0.087 DBMET03594 0.089 0.086 DBMET03595 | ||
| 0.067 | 0.052 | 0.109 | Peroxisome proliferator-activated receptor gamma agonist | 0.109 0.023 DBMET03594 | DBMET03594 | |
| 0.029 | 0.018 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 DBMET03593 0.027 0.025 DBMET03595 0.027 0.023 DBMET03596 | DBMET03593 | |
| 0.026 | 0.015 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.066 0.005 DBMET03593 0.022 0.019 DBMET03594 0.023 0.018 DBMET03595 0.024 0.016 DBMET03596 | DBMET03593 | |
| 0.138 | 0.129 | 0.32 | DNA methylase inhibitor | 0.16 0.109 DBMET03593 0.32 0.023 DBMET03594 0.199 0.08 DBMET03595 | DBMET03594 | |
| 0.023 | 0.014 | 0.024 | Adenosine kinase inhibitor | 0.024 0.013 DBMET03595 | DBMET03595 | |
| 0.065 | 0.057 | 0.085 | HIV-1 integrase inhibitor | 0.085 0.034 DBMET03594 0.066 0.054 DBMET03595 | DBMET03594 | |
| 0.054 | 0.047 | 0.089 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.058 0.042 DBMET03593 0.089 0.021 DBMET03594 0.066 0.034 DBMET03595 | DBMET03594 | |
| 0.114 | 0.109 | 0.258 | Cell wall synthesis inhibitor | 0.258 0.014 DBMET03593 0.161 0.055 DBMET03594 0.126 0.091 DBMET03595 | DBMET03593 | |
| 0.028 | 0.025 | 0.132 | Squalene synthetase inhibitor | 0.04 0.018 DBMET03593 0.032 0.022 DBMET03594 0.132 0.004 DBMET03596 | DBMET03596 | |
| 0.057 | 0.055 | 0.098 | Leukotriene antagonist | 0.098 0.023 DBMET03594 | DBMET03594 | |
| 0.047 | 0.045 | 0.07 | Glucose-6-phosphate translocase inhibitor | 0.07 0.015 DBMET03593 | DBMET03593 | |
| 0.071 | 0.069 | 0.071 | Interferon agonist | |||
| 0.041 | 0.04 | 0.045 | Microtubule stabilization | 0.045 0.035 DBMET03593 | DBMET03593 | |
| 0.017 | 0.017 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.019 0.015 DBMET03594 0.019 0.015 DBMET03595 | DBMET03595 | |
| 0.013 | 0.013 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.01 DBMET03595 | DBMET03595 | |
| 0.01 | 0.011 | 0.014 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET03594 0.014 0.005 DBMET03595 | DBMET03595 | |
| 0.065 | 0.067 | 0.094 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.071 0.06 DBMET03594 0.094 0.041 DBMET03595 | DBMET03595 | |
| 0.063 | 0.066 | 0.115 | Carbonic anhydrase XIII inhibitor | 0.115 0.031 DBMET03594 0.11 0.033 DBMET03595 | DBMET03594 | |
| 0.044 | 0.048 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET03593 0.046 0.044 DBMET03595 | DBMET03593 | |
| 0.208 | 0.214 | 0.381 | Alpha-glucosidase inhibitor | 0.381 0.123 DBMET03593 0.291 0.164 DBMET03594 0.334 0.143 DBMET03595 | DBMET03593 | |
| 0.057 | 0.063 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET03593 | DBMET03593 | |
| 0.052 | 0.059 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 DBMET03593 | DBMET03593 | |
| 0.063 | 0.071 | 0.073 | CDC25A inhibitor | 0.073 0.051 DBMET03594 | DBMET03594 | |
| 0.034 | 0.046 | 0.045 | Thymidine kinase inhibitor | 0.045 0.024 DBMET03595 | DBMET03595 | |
| 0.035 | 0.047 | 0.057 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET03594 0.057 0.023 DBMET03595 | DBMET03595 | |
| 0.01 | 0.023 | 0.036 | Prostacyclin agonist | 0.036 0.005 DBMET03594 | DBMET03594 | |
| 0.056 | 0.07 | 0.071 | Beta 2 adrenoreceptor agonist | 0.071 0.018 DBMET03596 | DBMET03596 | |
| 0.085 | 0.099 | 0.133 | Beta glucuronidase inhibitor | 0.133 0.035 DBMET03593 0.103 0.065 DBMET03595 | DBMET03593 | |
| 0.124 | 0.139 | 0.278 | DNA methyltransferase I inhibitor | 0.13 0.129 DBMET03593 0.278 0.035 DBMET03594 0.169 0.087 DBMET03595 | DBMET03594 | |
| 0.039 | 0.054 | 0.128 | Aldose reductase inhibitor | 0.053 0.037 DBMET03593 0.128 0.013 DBMET03594 0.052 0.037 DBMET03595 | DBMET03594 | |
| 0.079 | 0.096 | 0.096 | Glutamate release inhibitor | 0.096 0.049 DBMET03593 0.091 0.06 DBMET03594 | DBMET03593 | |
| 0.082 | 0.1 | 0.101 | Phosphodiesterase 6D inhibitor | 0.093 0.068 DBMET03593 0.101 0.049 DBMET03595 | DBMET03595 | |
| 0.022 | 0.04 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET03593 0.025 0.024 DBMET03595 | DBMET03593 | |
| 0.024 | 0.044 | 0.049 | Phosphoglycerate kinase inhibitor | 0.04 0.019 DBMET03594 0.049 0.014 DBMET03595 | DBMET03595 | |
| 0.033 | 0.054 | 0.06 | Peroxisome proliferator-activated receptor alpha agonist | 0.06 0.026 DBMET03594 | DBMET03594 | |
| 0.147 | 0.17 | 0.216 | Interleukin agonist | 0.216 0.106 DBMET03593 0.207 0.114 DBMET03594 0.172 0.146 DBMET03595 | DBMET03593 | |
| 0.02 | 0.043 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 DBMET03595 | DBMET03595 | |
| 0.049 | 0.073 | 0.057 | Leukotriene C antagonist | 0.057 0.037 DBMET03594 | DBMET03594 | |
| 0.011 | 0.035 | 0.025 | Thyroid hormone alpha agonist | 0.025 0.005 DBMET03594 | DBMET03594 | |
| 0.083 | 0.107 | 0.13 | Mucolytic | 0.13 0.046 DBMET03594 | DBMET03594 | |
| 0.05 | 0.074 | 0.09 | Leukotriene synthesis inhibitor | 0.09 0.032 DBMET03594 | DBMET03594 | |
| 0.011 | 0.036 | 0.055 | Prostaglandin EP2 agonist | 0.055 0.005 DBMET03594 0.027 0.013 DBMET03595 | DBMET03594 | |
| 0.069 | 0.097 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 DBMET03594 0.08 0.077 DBMET03595 | DBMET03594 | |
| 0.034 | 0.061 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET03593 | DBMET03593 | |
| 0.019 | 0.048 | 0.04 | Prostaglandin agonist | 0.04 0.013 DBMET03594 | DBMET03594 | |
| 0.124 | 0.157 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.132 0.109 DBMET03594 0.133 0.105 DBMET03595 | DBMET03595 | |
| 0.032 | 0.064 | 0.037 | Leukotriene C4 antagonist | 0.037 0.033 DBMET03594 | DBMET03594 | |
| 0.038 | 0.071 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.039 DBMET03594 | DBMET03594 | |
| 0.038 | 0.08 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.046 DBMET03594 0.055 0.04 DBMET03595 | DBMET03595 | |
| 0.123 | 0.166 | 0.153 | Heat shock protein 70 antagonist | 0.153 0.038 DBMET03594 0.137 0.088 DBMET03595 | DBMET03594 | |
| 0.044 | 0.089 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 DBMET03593 0.052 0.051 DBMET03594 | DBMET03593 | |
| 0.071 | 0.116 | 0.079 | T cell inhibitor | 0.079 0.069 DBMET03594 | DBMET03594 | |
| 0.056 | 0.102 | 0.072 | MDM2 inhibitor | 0.072 0.033 DBMET03594 | DBMET03594 | |
| 0.016 | 0.063 | 0.038 | Thyroid hormone agonist | 0.038 0.007 DBMET03594 | DBMET03594 | |
| 0.036 | 0.083 | 0.057 | Neuraminidase inhibitor | 0.057 0.047 DBMET03593 | DBMET03593 | |
| 0.069 | 0.121 | 0.102 | ABCA1 expression enhancer | 0.102 0.048 DBMET03594 | DBMET03594 | |
| 0.062 | 0.121 | 0.123 | Alcohol dehydrogenase inhibitor | 0.123 0.033 DBMET03594 0.113 0.04 DBMET03595 | DBMET03594 | |
| 0.139 | 0.2 | 0.155 | MAP kinase kinase 5 inhibitor | 0.155 0.133 DBMET03595 | DBMET03595 | |
| 0.008 | 0.069 | 0.024 | Prostaglandin E2 agonist | 0.024 0.015 DBMET03594 | DBMET03594 | |
| 0.033 | 0.097 | 0.062 | Leukotriene B4 antagonist | 0.062 0.026 DBMET03594 | DBMET03594 | |
| 0.092 | 0.156 | 0.227 | Anticoagulant | 0.227 0.044 DBMET03593 0.144 0.085 DBMET03594 0.147 0.083 DBMET03596 | DBMET03593 | |
| 0.094 | 0.158 | 0.186 | Phospholipase A2 inhibitor | 0.13 0.1 DBMET03593 0.186 0.05 DBMET03594 0.119 0.118 DBMET03595 | DBMET03594 | |
| 0.023 | 0.088 | 0.051 | Thromboxane A2 antagonist | 0.051 0.036 DBMET03594 | DBMET03594 | |
| 0.064 | 0.132 | 0.082 | DNA directed RNA polymerase inhibitor | 0.082 0.081 DBMET03595 | DBMET03595 | |
| 0.025 | 0.094 | 0.055 | Thromboxane antagonist | 0.055 0.036 DBMET03594 | DBMET03594 | |
| 0.097 | 0.165 | 0.176 | Arachidonic acid antagonist | 0.176 0.058 DBMET03594 0.123 0.122 DBMET03595 0.126 0.117 DBMET03596 | DBMET03594 | |
| 0.033 | 0.114 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET03596 | DBMET03596 | |
| 0.108 | 0.192 | 0.243 | Aldehyde oxidase inhibitor | 0.243 0.085 DBMET03595 | DBMET03595 | |
| 0.033 | 0.124 | 0.088 | Adrenaline uptake inhibitor | 0.088 0.023 DBMET03596 | DBMET03596 | |
| 0.042 | 0.143 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.051 DBMET03594 | DBMET03594 | |
| 0.02 | 0.122 | 0.077 | Prostaglandin EP2 antagonist | 0.077 0.029 DBMET03594 | DBMET03594 | |
| 0.086 | 0.19 | 0.118 | Mannose-6-phosphate isomerase inhibitor | 0.118 0.104 DBMET03594 0.118 0.105 DBMET03595 | DBMET03595 | |
| 0.043 | 0.151 | 0.072 | Adrenaline agonist | 0.072 0.069 DBMET03596 | DBMET03596 | |
| 0.009 | 0.118 | 0.069 | Prostacyclin antagonist | 0.069 0.007 DBMET03594 | DBMET03594 | |
| 0.021 | 0.13 | 0.111 | Dopamine transporter inhibitor | 0.111 0.009 DBMET03596 | DBMET03596 | |
| 0.026 | 0.135 | 0.053 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.052 DBMET03594 | DBMET03594 | |
| 0.033 | 0.143 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.054 DBMET03596 | DBMET03596 | |
| 0.156 | 0.269 | 0.186 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.183 DBMET03594 | DBMET03594 | |
| 0.01 | 0.123 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 DBMET03594 | DBMET03594 | |
| 0.047 | 0.166 | 0.106 | Mediator release inhibitor | 0.106 0.063 DBMET03594 0.104 0.066 DBMET03596 | DBMET03594 | |
| 0.077 | 0.205 | 0.136 | Diuretic | 0.126 0.098 DBMET03593 0.136 0.089 DBMET03594 | DBMET03594 | |
| 0.081 | 0.21 | 0.121 | Hexokinase inhibitor | 0.121 0.117 DBMET03595 | DBMET03595 | |
| 0.034 | 0.164 | 0.111 | Topoisomerase II alpha inhibitor | 0.111 0.033 DBMET03593 | DBMET03593 | |
| 0.047 | 0.183 | 0.175 | Topoisomerase II inhibitor | 0.175 0.039 DBMET03593 | DBMET03593 | |
| 0.014 | 0.153 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 DBMET03594 | DBMET03594 | |
| 0.038 | 0.21 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.049 DBMET03594 | DBMET03594 | |
| 0.178 | 0.349 | 0.249 | 5 Hydroxytryptamine release inhibitor | 0.249 0.229 DBMET03595 | DBMET03595 | |
| 0.117 | 0.295 | 0.232 | Angiogenesis inhibitor | 0.232 0.137 DBMET03593 | DBMET03593 | |
| 0.011 | 0.237 | 0.089 | Prostaglandin antagonist | 0.089 0.02 DBMET03594 | DBMET03594 | |
| 0.07 | 0.301 | 0.163 | Platelet aggregation inhibitor | 0.163 0.113 DBMET03594 | DBMET03594 | |
| 0.072 | 0.333 | 0.153 | Succinate dehydrogenase inhibitor | 0.153 0.107 DBMET03594 | DBMET03594 | |
| 0.01 | 0.273 | 0.063 | 5 Hydroxytryptamine uptake inhibitor | 0.063 0.044 DBMET03596 | DBMET03596 | |
| 0.004 | 0.292 | 0.028 | Prostaglandin D2 antagonist | 0.028 0.013 DBMET03594 | DBMET03594 | |
| 0.091 | 0.384 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.07 DBMET03593 | DBMET03593 | |
| 0.042 | 0.349 | 0.162 | Dual specificity phosphatase 3 inhibitor | 0.162 0.086 DBMET03594 | DBMET03594 | |
| 0.02 | 0.349 | 0.062 | Factor IXa inhibitor | 0.062 0.025 DBMET03593 | DBMET03593 | |
| 0.052 | 0.59 | 0.136 | MAP kinase kinase 4 inhibitor | 0.136 0.095 DBMET03596 | DBMET03596 | |
| 0.005 | 0.668 | 0.116 | Check point kinase 2 inhibitor | 0.116 0.052 DBMET03596 | DBMET03596 | |
| 0.02 | 0.985 | 0.233 | MAP kinase kinase 3 inhibitor | 0.233 0.052 DBMET03596 | DBMET03596 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |